Concepedia

Olivier Van Der Meeren

OV

34

Publications

2.2K

Citations

20

H-Index

2010

Active since

Affiliations

GlaxoSmithKline (Belgium)(Current)

GlaxoSmithKline (India)

University of Cape Town

South African Medical Research Council

Aurum Institute

Olivier Van Der Meeren is an author at GlaxoSmithKline (Belgium) specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

2010–2021

34

Publications

34

Final Analysis of a Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Dereck Tait, Mark Hatherill, Olivier Van Der Meeren et al. · New England Journal of Medicine · 2019 · 561 citations · Full text

Phase 2b Controlled Trial of M72/AS01 <sub>E</sub> Vaccine to Prevent Tuberculosis

Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba et al. · New England Journal of Medicine · 2018 · 392 citations · Full text

Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in Adults

Glenda Gray, Linda‐Gail Bekker, Fatima Laher et al. · New England Journal of Medicine · 2021 · 221 citations · Full text

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

Jussi Mertsola, Olivier Van Der Meeren, Qiushui He et al. · Clinical Infectious Diseases · 2010 · 96 citations · Full text

Effect of a Prepregnancy Pertussis Booster Dose on Maternal Antibody Titers in Young Infants

Elke Leuridan, Niel Hens, Natasja Peeters et al. · The Pediatric Infectious Disease Journal · 2011 · 95 citations

, , +14

Rows per page

1–5 of 34